Release Date: 30/08/23 08:09 Summary: SILK FY23 Results Price Sensitive: Yes Download Document 107.43KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling